
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


SWK Holdings Corp (SWKH)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: SWKH (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $18.5
1 Year Target Price $18.5
0 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 12.98% | Avg. Invested days 48 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 200.43M USD | Price to earnings Ratio 11.7 | 1Y Target Price 18.5 |
Price to earnings Ratio 11.7 | 1Y Target Price 18.5 | ||
Volume (30-day avg) 1 | Beta 0.24 | 52 Weeks Range 8.85 - 17.90 | Updated Date 10/19/2025 |
52 Weeks Range 8.85 - 17.90 | Updated Date 10/19/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.41 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 46.55% | Operating Margin (TTM) 56.9% |
Management Effectiveness
Return on Assets (TTM) 5.74% | Return on Equity (TTM) 6.58% |
Valuation
Trailing PE 11.7 | Forward PE - | Enterprise Value 203076543 | Price to Sales(TTM) 5.36 |
Enterprise Value 203076543 | Price to Sales(TTM) 5.36 | ||
Enterprise Value to Revenue 4.55 | Enterprise Value to EBITDA 7.08 | Shares Outstanding 12147391 | Shares Floating 2318087 |
Shares Outstanding 12147391 | Shares Floating 2318087 | ||
Percent Insiders 6.44 | Percent Institutions 87.38 |
Upturn AI SWOT
SWK Holdings Corp

Company Overview
History and Background
SWK Holdings Corporation (SWKH) was founded in 2010. It is a specialized finance company focusing on the healthcare sector. The company provides financing to companies with products and services that improve the quality of life.
Core Business Areas
- Healthcare Finance: SWK Holdings provides specialized financing solutions to healthcare companies, including term loans, royalty monetization, and other structured finance products. The focus is on revenue-generating products or those nearing commercialization.
Leadership and Structure
Winston Black is the Chief Executive Officer. The company has a board of directors overseeing its operations and strategy. It operates with a focused team managing investments and portfolio companies.
Top Products and Market Share
Key Offerings
- Term Loans: SWK provides term loans to healthcare companies, primarily those seeking growth capital or refinancing. Market share data not publicly available. Competitors include other specialty finance firms focused on healthcare, and traditional banks with healthcare lending practices.
- Royalty Monetization: SWK offers royalty monetization solutions, allowing companies to receive upfront capital in exchange for future royalty streams. Market share data not publicly available. Competitors are specialty finance firms and investment funds specializing in royalty monetization.
Market Dynamics
Industry Overview
The healthcare finance industry is driven by the need for capital among healthcare companies developing and commercializing new products and services. The sector is growing with innovation and demographic changes. Funding is needed due to regulatory hurdles, long development timelines and market uncertainty.
Positioning
SWK Holdings positions itself as a specialized finance partner to healthcare companies, differentiating through its expertise in the healthcare sector and its flexible financing solutions.
Total Addressable Market (TAM)
The TAM for healthcare finance is estimated in the tens of billions of dollars annually. SWK focuses on a niche within this market, and their TAM portion is estimated to be in the billions. They are well positioned to capture market share in their niche.
Upturn SWOT Analysis
Strengths
- Specialized expertise in healthcare finance
- Flexible financing solutions
- Experienced management team
- Strong portfolio of investments
Weaknesses
- Concentration in the healthcare sector
- Relatively small size compared to larger financial institutions
- Dependence on the success of portfolio companies
Opportunities
- Increasing demand for capital among healthcare companies
- Expanding into new healthcare sub-sectors
- Strategic acquisitions to grow the portfolio
- Rising interest rates increasing net interest income
Threats
- Economic downturn impacting healthcare spending
- Increased competition from other finance providers
- Regulatory changes in the healthcare industry
- Failure of portfolio companies to achieve commercial success
Competitors and Market Share
Key Competitors
- ORCC
- TPVG
- PSEC
Competitive Landscape
SWK has strengths in its expertise. ORCC, TPVG, and PSEC have stronger balance sheets.
Major Acquisitions
Arthrex Royalty Portfolio
- Year: 2022
- Acquisition Price (USD millions): 94
- Strategic Rationale: Augmented future royalty streams and increased cash flow.
Growth Trajectory and Initiatives
Historical Growth: SWK Holdings has demonstrated a solid growth trajectory through strategic investments and effective management of its portfolio.
Future Projections: Future growth is projected to continue based on analysts' estimates and the company's pipeline of investment opportunities.
Recent Initiatives: Recent initiatives include expanding their financing solutions and exploring opportunities in new healthcare sub-sectors.
Summary
SWK Holdings is a specialized finance company with a strong focus on the healthcare sector. Its expertise and flexible financing solutions have driven consistent growth. However, dependence on its portfolio companies and smaller size are drawbacks. Future success depends on strong portfolio management and economic stability.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Financial news sources
- Analyst reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate. Please consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SWK Holdings Corp
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 1999-09-22 | CEO & President Mr. Jody. D Staggs | ||
Sector Financial Services | Industry Asset Management | Full time employees 29 | Website https://www.swkhold.com |
Full time employees 29 | Website https://www.swkhold.com |
SWK Holdings Corporation is a venture debt firm specializing in early stage, seed/startup, series-A to series-D and growth capital investments. It seeks to invest in healthcare sectors including biopharma, medical devices, diagnostics, life science tools, selective healthcare service and HIT companies; technology; software; SaaS; and green energy/sustainability. It seeks to make investments between $5 million and $20 million, it may also invest higher. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas. SWK Holdings Corporation operates as a subsidiary of Carlson Capital, L.P.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.